The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lodie, T. A.
Right arrow Articles by Fenton, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lodie, T. A.
Right arrow Articles by Fenton, M. J.
The Journal of Immunology, 1998, 161: 268-276.
Copyright © 1998 by The American Association of Immunologists

Both PU.1 and Nuclear Factor-{kappa}B Mediate Lipopolysaccharide-Induced HIV-1 Long Terminal Repeat Transcription in Macrophages1

Tracey A. Lodie*,{dagger}, Marshall Reiner{ddagger}, Salvatore Coniglio{ddagger}, Gregory Viglianti{ddagger} and Matthew J. Fenton2,*,{dagger}

* Pulmonary Center and Departments of {dagger} Pathology and {ddagger} Microbiology, Boston University School of Medicine, Boston, MA 02118

We recently reported that LPS stimulation of monocytic cells leads to the activation of PU.1, a member of the Ets family of transcription factors. Phosphorylation of PU.1 by protein kinase CK2 was found to up-regulate its trans-activation function, but not its DNA binding activity. Previous studies suggested that Ets proteins could bind to NF-{kappa}B motifs at the tetrameric core sequence TTCC. In macrophages, LPS-inducible HIV-1 gene expression is mediated in part by binding of NF-{kappa}B to identical tandem binding sites located within the long terminal repeat (LTR). Thus, we performed additional studies to determine whether PU.1 also played a role in regulating HIV-1 gene expression in macrophages. Our functional studies revealed that activation of the HIV-1 LTR in LPS-stimulated cells requires both NF-{kappa}B and PU.1. Extensive mutagenesis of the HIV-1 LTR revealed that PU.1-dependent activation requires the Ets motif within the upstream NF-{kappa}B site, whereas NF-{kappa}B itself binds to the downstream site. We also found that insertion of five additional nucleotides between the NF-{kappa}B sites abolished LPS inducibility, suggesting a direct interaction between factors that bind these sites. Lastly, we found that mutation of PU.1 at serine 148, which prevents its phosphorylation by CK2, blocked its ability to activate the HIV-1 LTR in response to LPS. These effects were promoter specific because PU.1 did not affect LPS-inducible activation of a distinct NF-{kappa}B-dependent promoter. While these data do not demonstrate direct binding of PU.1 to the HIV-1 LTR, they illustrate a novel role for PU.1 in activation of the HIV-1 LTR by LPS.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. D. Liang, Y. Zhang, D. McDevit, S. Marecki, and B. S. Nikolajczyk
The Interleukin-1beta Gene Is Transcribed from a Poised Promoter Architecture in Monocytes
J. Biol. Chem., April 7, 2006; 281(14): 9227 - 9237.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. D. Wewers, S. Lemeshow, A. Lehman, T. L. Clanton, and P. T. Diaz
Lung CD4 Lymphocytes Predict Survival in Asymptomatic HIV Infection
Chest, October 1, 2005; 128(4): 2262 - 2267.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. McDevit, L. Perkins, M. L. Atchison, and B. S. Nikolajczyk
The Ig{kappa}3' Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association
J. Immunol., March 1, 2005; 174(5): 2834 - 2842.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Hanley, H. L. B. Kiefer, A. C. Schnitzler, J. E. Marcello, and G. A. Viglianti
Retinoid-Dependent Restriction of Human Immunodeficiency Virus Type 1 Replication in Monocytes/Macrophages
J. Virol., March 15, 2004; 78(6): 2819 - 2830.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. M. Johansen, A. Iwama, T. A. Lodie, K. Sasaki, D. W. Felsher, T. R. Golub, and D. G. Tenen
c-Myc Is a Critical Target for C/EBP{alpha} in Granulopoiesis
Mol. Cell. Biol., June 1, 2001; 21(11): 3789 - 3806.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
P. Regenhard, R. Goethe, and L. Phi-van
Involvement of PKA, PKC, and Ca2+ in LPS-activated expression of the chicken lysozyme gene
J. Leukoc. Biol., April 1, 2001; 69(4): 651 - 658.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
O. Equils, E. Faure, L. Thomas, Y. Bulut, S. Trushin, and M. Arditi
Bacterial Lipopolysaccharide Activates HIV Long Terminal Repeat Through Toll-Like Receptor 4
J. Immunol., February 15, 2001; 166(4): 2342 - 2347.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. P. Sester, S. Naik, S. J. Beasley, D. A. Hume, and K. J. Stacey
Phosphorothioate Backbone Modification Modulates Macrophage Activation by CpG DNA
J. Immunol., October 15, 2000; 165(8): 4165 - 4173.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Stutz and M. Woisetschlager
Functional Synergism of STAT6 with Either NF-{kappa}B or PU.1 to Mediate IL-4-Induced Activation of IgE Germline Gene Transcription
J. Immunol., October 15, 1999; 163(8): 4383 - 4391.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Marecki, M. L. Atchison, and M. J. Fenton
Differential Expression and Distinct Functions of IFN Regulatory Factor 4 and IFN Consensus Sequence Binding Protein in Macrophages
J. Immunol., September 1, 1999; 163(5): 2713 - 2722.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. Smith Jr., V. S. Carl, T. Lodie, and M. J. Fenton
Secretory Interleukin-1 Receptor Antagonist Gene Expression Requires both a PU.1 and a Novel Composite NF-kappa B/PU.1/ GA-binding Protein Binding Site
J. Biol. Chem., September 11, 1998; 273(37): 24272 - 24279.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Krehan, H. Ansuini, O. Bocher, S. Grein, U. Wirkner, and W. Pyerin
Transcription Factors Ets1, NF-kappa B, and Sp1 Are Major Determinants of the Promoter Activity of the Human Protein Kinase CK2alpha Gene
J. Biol. Chem., June 9, 2000; 275(24): 18327 - 18336.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.